A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior

Neuroscience and Biobehavioral Reviews

Volumn 42, Issue , 2014, Pages 116-131

  McLaughlin, Ryan J ^a   Hill, Matthew N ^b,c   Gorzalka, Boris B ^d  

^a MCGILL UNIVERSITY   (Canada)

^b Department of Cell Biology and Anatomy and Department of Psychiatry ^*  (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Emotional behavior; Endocannabinoid system; Prefrontal cortex; Stress

Indexed keywords

CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; MONOAMINE;

ANXIETY; AVERSION; BASOLATERAL AMYGDALA; BRAIN DEPTH STIMULATION; CHRONIC STRESS; COPING BEHAVIOR; DORSAL RAPHE NUCLEUS; EMOTIONALITY; GABAERGIC TRANSMISSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERNEURON; MENTAL DISEASE; NEGATIVE FEEDBACK; NERVE CELL NETWORK; NEUROANATOMY; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NONHUMAN; PERIKARYON; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; STEADY STATE; STRESS; STRIA TERMINALIS; ANIMAL; BIOLOGICAL MODEL; BRAIN; EMOTION; MENTAL STRESS; METABOLISM; MOOD DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; EMOTIONS; ENDOCANNABINOIDS; HUMANS; MODELS, NEUROLOGICAL; MOOD DISORDERS; PREFRONTAL CORTEX; STRESS, PSYCHOLOGICAL;

EID: 84896039080     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.02.006     Document Type: Review

References (236)

1. Aguiar D.C., Terzian A.L., Guimarães F.S., Moreira F.A. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats. Psychopharmacology (Berl.) 2009, 205:217-225.
2. Ahn K., McKinney M.K., Cravatt B.F. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem. Rev. 2008, 108:1687-1707.
3. Aso E., Ozaita A., Valdizan E.M., Ledent C., Pazos A., Maldonado R., Valverde O. BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J. Neurochem. 2008, 105:565-572.
4. Auclair N., Otani S., Soubrie P., Crepel F. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J. Neurophysiol. 2000, 83:3287-3293.
5. Bambico F.R., Katz N., Debonnel G., Gobbi G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J. Neurosci. 2007, 27:11700-11711.
6. Barbas H. Architecture and cortical connections of the prefrontal cortex in the rhesus monkey. Adv. Neurol. 1992, 57:91-115.
7. Barna I., Zelena D., Arszovszki A.C., Ledent C. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice. Life Sci. 2004, 75:2959-2970.
8. Bisogno T. Endogenous cannabinoids: structure and metabolism. J. Neuroendocrinol. 2008, 20:1-9.
9. Bitencourt R.M., Pamplona F.A., Takahashi R.N. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur. Neuropsychopharmacol. 2008, 18:849-859.
10. Bodor A.L., Katona I., Nyiri G., Mackie K., Ledent C., Hajos N., Freund T.F. Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J. Neurosci. 2005, 25:6845-6856.
11. Bonn-Miller M.O., Vujanovic A.A., Drescher K.D. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder. Psychol. Addict. Behav. 2011, 25:485-491.
12. Bortolato M., Mangieri R.A., Fu J., Kim J.H., Arguello O., Duranti A., Tontini A., Mor M., Tarzia G., Piomelli D. Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol. Psychiatry 2007, 62:1103-1110.
13. Botteron K.N., Raichle M.E., Drevets W.C., Heath A.C., Todd R.D. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biol. Psychiatry 2002, 51:342-344.
14. Bovasso G.B. Cannabis abuse as a risk factor for depressive symptoms. Am. J. Psychiatry 2001, 158:2033-2037.
15. Brown V.J., Bowman E.M. Rodent models of prefrontal cortical function. Trends Neurosci. 2002, 25:340-343.
16. Busquets-Garcia A., Puighermanal E., Pastor A., de la Torre R., Maldonado R., Ozaita A. Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses. Biol. Psychiatry 2011, 70:479-486.
17. Campos A.C., Moreira F.A., Gomes F.V., Del Bel E.A., Guimaraes F.S. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos. Trans. R. Soc. B 2012, 367:3364-3378.
18. Carmichael S.T., Price J.L. Architectonic subdivision of the orbital and medial prefrontal cortex in the macaque monkey. J. Comp. Neurol. 1994, 346:366-402.
19. Carr D.B., Sesack S.R. Dopamine terminals synapse on callosal projection neurons in the rat prefrontal cortex. J. Comp. Neurol. 2000, 425:275-283.
20. Carr D.B., Sesack S.R. GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse 2000, 38:114-123.
21. Cerqueira J.J., Mailliet F., Almeida O.F., Jay T.M., Sousa N. The prefrontal cortex as a key target of the maladaptive response to stress. J. Neurosci. 2007, 27:2781-2787.
22. Cerqueira J.J., Taipa R., Uylings H.B., Almeida O.F., Sousa N. Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing corticosteroid regimens. Cereb. Cortex 2007, 17:1998-2006.
23. Chiba T. Collateral projection from the amygdalo--hippocampal transition area and CA1 to the hypothalamus and medial prefrontal cortex in the rat. Neurosci. Res. 2000, 38:373-383.
24. Chiu C.Q., Puente N., Grandes P., Castillo P.E. Dopaminergic Modulation of Endocannabinoid-Mediated Plasticity at GABAergic Synapses in the Prefrontal Cortex. J. Neurosci. 2010, 30:7236-7248.
25. Choi K., Le T., McGuire J., Xing G., Zhang L., Li H., Parker C.C., Johnson L.R., Ursano R.J. Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear. J. Psychiatr. Res. 2012, 46:882-889.
26. Cook S.C., Wellman C.L. Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J. Neurobiol. 2004, 60:236-248.
27. Cornelius J.R., Kirisci L., Reynolds M., Clark D.B., Hayes J., Tarter R. PTSD contributes to teen and young adult cannabis use disorders. Addict. Behav. 2010, 35:91-94.
28. Cota D., Steiner M.A., Marsicano G., Cervino C., Herman J.P., Grubler Y., Stalla J., Pasquali R., Lutz B., Stalla G.K., Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 2007, 148:1574-1581.
29. Cullinan W.E., Herman J.P., Battaglia D.F., Akil H., Watson S.J. Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience 1995, 64:477-505.
30. Dalley J.W., Cardinal R.N., Robbins T.W. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci. Biobehav. Rev. 2004, 28:771-784.
31. de Freitas R.L., Salgado-Rohner C.J., Hallak J.E., de Souza Crippa J.A., Coimbra N.C. Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor. Int. J. Neuropsychopharmacol. 2013, 16:1781-1798.
32. Dean B., Sundram S., Bradbury R., Scarr E., Copolov D. Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 2001, 103:9-15.
33. Delgado M.R., Nearing K.I., LeDoux J.E., Phelps E.A. Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron 2008, 59:829-838.
34. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
35. Di Marzo V., Melck D., Bisogno T., De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 1999, 21:521-528.
36. Dias-Ferreira E., Sousa J.C., Melo I., Morgado P., Mesquita A.R., Cerqueira J.J., Costa R.M., Sousa N. Chronic stress causes frontostriatal reorganization and affects decision-making. Science 2009, 325:621-625.
37. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J. Neurosci. 1993, 13:3839-3847.
38. Drevets W.C., Bogers W., Raichle M.E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur. Neuropsychopharmacol. 2002, 12:527-544.
39. Drevets W.C., Ongur D., Price J.L. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol. Psychiatry 1998, 3:190-221. 220-226.
40. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct. Funct. 2008, 213:93-118.
41. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386:824-827.
42. Drevets W.C., Savitz J., Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr. 2008, 13:663-681.
43. Duncan G.E., Johnson K.B., Breese G.R. Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity. J. Neurosci. 1993, 13:3932-3943.
44. Egertova M., Cravatt B.F., Elphick M.R. Comparative analysis of fatty acid amide hydrolase and CB1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 2003, 119:481-496.
45. Eggan S.M., Lewis D.A. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb. Cortex 2007, 17:175-191.
46. Eiland L., Romeo R.D. Stress and the developing adolescent brain. Neuroscience 2013, 249:162-171.
47. Ferraro L., Tomasini M.C., Cassano T., Bebe B.W., Siniscalchi A., O'Connor W.T., Magee P., Tanganelli S., Cuomo V., Antonelli T. Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels. J. Neurosci. Res. 2001, 66:298-302.
48. Ferraro L., Tomasini M.C., Gessa G.L., Bebe B.W., Tanganelli S., Antonelli T. The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study. Cereb. Cortex 2001, 11:728-733.
49. Figueiredo H.F., Bruestle A., Bodie B., Dolgas C.M., Herman J.P. The medial prefrontal cortex differentially regulates stress-induced c-fos expression in the forebrain depending on type of stressor. Eur. J. Neurosci. 2003, 18:2357-2364.
50. Fogaca M.V., Aguiar D.C., Moreira F.A., Guimaraes F.S. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior. Neuropharmacology 2012, 63:202-210.
51. Fortin D.A., Levine E.S. Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. Cereb. Cortex 2007, 17:163-174.
52. Fraser G.A. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci. Ther. 2009, 15:84-88.
53. Freitas-Ferrari M.C., Hallak J.E.C., Trzesniak C., Santos A., Machado-de-Sousa J.P., Chagas M.H.N., Nardi A.E., Crippa J.A.S. Neuroimaging in social anxiety disorder: a systematic review of the literature. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:565-580.
54. Gabbott P.L., Warner T.A., Jays P.R., Salway P., Busby S.J. Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. J. Comp. Neurol. 2005, 492:145-177.
55. García-Gutiérrez M.S., Perez-Ortiz J.M., Gutierrez-Adan A., Manzanares J. Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors. Br. J. Pharmacol. 2010, 160:1773-1784.
56. Gao Y., Vasilyev D.V., Goncalves M.B., Howell F.V., Hobbs C., Reisenberg M., Shen R., Zhang M.Y., Strassle B.W., Lu P., Mark L., Piesla M.J., Deng K., Kouranova E.V., Ring R.H., Whiteside G.T., Bates B., Walsh F.S., Williams G., Pangalos M.N., Samad T.A., Doherty P. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J. Neurosci. 2010, 30:2017-2024.
57. Gaoni Y., Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 1964, 86:1646-1647.
58. Gaykema R.P., Gaal G., Traber J., Hersh L.B., Luiten P.G. The basal forebrain cholinergic system: efferent and afferent connectivity and long-term effects of lesions. Acta Psychiatr. Scand. Suppl. 1991, 366:14-26.
59. Ghashghaei H., Hilgetag C.C., Barbas H. Sequence of information processing for emotions based on the anatomic dialogue between prefrontal cortex and amygdala. Neuroimage 2007, 34:905-923.
60. Glass M., Dragunow M., Faull R.L.M. Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997, 77:299-318.
61. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., Cassano T., Morgese M.G., Debonnel G., Duranti A., Tontini A., Tarzia G., Mor M., Trezza V., Goldberg S.R., Cuomo V., Piomelli D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:18620-18625.
62. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., Uhl G.R. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 2006, 1071:10-23.
63. Gorzalka B.B., Hill M.N., Hillard C.J. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci. Biobehav. Rev. 2008, 32:1152-1160.
64. Hajos M., Richards C.D., Szekely A.D., Sharp T. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 1998, 87:95-108.
65. Haller J., Varga B., Ledent C., Barna I., Freund T.F. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur. J. Neurosci. 2004, 19:1906-1912.
66. Hamani C., Diwan M., Isabella S., Lozano A.M., Nobrega J.N. Effects of different stimulation parameters on the antidepressant-like response of medial prefrontal cortex deep brain stimulation in rats. J. Psychiatr. Res. 2010, 44:683-687.
67. Hamani C., Diwan M., Macedo C.E., Brandao M.L., Shumake J., Gonzalez-Lima F., Raymond R., Lozano A.M., Fletcher P.J., Nobrega J.N. Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biol. Psychiatry 2010, 67:117-124.
68. Hamani C., Machado D.C., Hipolide D.C., Dubiela F.P., Suchecki D., Macedo C.E., Tescarollo F., Martins U., Covolan L., Nobrega J.N. Deep brain stimulation reverses anhedonic-like behavior in a chronic model of depression: role of serotonin and brain derived neurotrophic factor. Biol. Psychiatry 2012, 71:30-35.
69. Hamani C., Nobrega J.N. Deep brain stimulation in clinical trials and animal models of depression. Eur. J. Neurosci. 2010, 32:1109-1117.
70. Hamani C., Nobrega J.N., Lozano A.M. Deep brain stimulation in clinical practice and in animal models. Clin. Pharmacol. Ther. 2010, 88:559-562.
71. Hasler G., Fromm S., Carlson P.J., Luckenbaugh D.A., Waldeciz T., Geraci M., Roiser J.P., Neumeister A., Meyers N., Charney D.S., Drevets W.C. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch. Gen. Psychiatry 2008, 65:521-531.
72. Hauer D., Schelling G., Gola H., Campolongo P., Morath J., Roozendaal B., Hamuni G., Karabatsiakis A., Atsak P., Vogeser M., Kolassa I.T. Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. PLoS ONE 2013, 8(5):e62741.
73. Heidbreder C.A., Groenewegen H.J. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci. Biobehav. Rev. 2003, 27:555-579.
74. Heng L.J., Beverley J.A., Steiner H., Tseng K.Y. Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areas. Synapse 2011, 65:278-286.
75. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., Decosta B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain - a quantitative in vitro autoradiographic study. J. Neurosci. 1991, 11:563-583.
76. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., Decosta B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:1932-1936.
77. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., Cullinan W.E. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front. Neuroendocrinol. 2003, 24:151-180.
78. Hill M.N., Bierer L.M., Makotkine I., Golier J.A., Galea S., McEwen B.S., Hillard C.J., Yehuda R. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks. Psychoneuroendocrinology 2013, 38:2952-2961.
79. Hill M.N., Carrier E.J., McLaughlin R.J., Morrish A.C., Meier S.E., Hillard C.J., Gorzalka B.B. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. J. Neurochem. 2008, 106:2322-2336.
80. Hill M.N., Gorzalka B.B. Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?. Behav. Pharmacol. 2005, 16:333-352.
81. Hill M.N., Hellemans K.G.C., Verma P., Gorzalka B.B., Weinberg J. Neurobiology of chronic mild stress: Parallels to major depression. Neurosci. Biobehav. Rev. 2012, 36:2085-2117.
82. Hill M.N., Hillard C.J., McEwen B.S. Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress. Cereb. Cortex 2011, 21:2056-2064.
83. Hill M.N., Ho W.S., Hillard C.J., Gorzalka B.B. Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents. J. Neural Transm. 2008, 115:1673-1679.
84. Hill M.N., McEwen B.S. Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:791-797.
85. Hill M.N., McLaughlin R.J., Bingham B., Shrestha L., Lee T.T.Y., Gray J.M., Hillard C.J., Gorzalka B.B., Viau V. Endogenous cannabinoid signaling is essential for stress adaptation. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9406-9411.
86. Hill M.N., McLaughlin R.J., Morrish A.C., Viau V., Floresco S.B., Hillard C.J., Gorzalka B.B. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology 2009, 34:2733-2745.
87. Hill M.N., McLaughlin R.J., Pan B., Fitzgerald M.L., Roberts C.J., Lee T.T.Y., Karatsoreos I.N., Mackie K., Viau V., Pickel V.M., McEwen B.S., Liu Q.S., Gorzalka B.B., Hillard C.J. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J. Neurosci. 2011, 31:10506-10515.
88. Hill M.N., Patel S., Carrier E.J., Rademacher D.J., Ormerod B.K., Hillard C.J., Gorzalka B.B. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 2005, 30:508-515.
89. Hill M.N., Tasker J.G. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience 2012, 204:5-16.
90. Hillard C.J. Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Prostaglandins Other Lipid Mediat. 2000, 61:3-18.
91. Hillard C.J., Hill M.N., Carrier E.J., Shi L.W.E.C., Gorzalka B.B. Regulation of cannabinoid receptor expression by chronic unpredictable stress in rats and mice. Soc. Neurosci. Abstr. 2006, 746:19.
92. Hirvonen J., Goodwin R.S., Li C.T., Terry G.E., Zoghbi S.S., Morse C., Pike V.W., Volkow N.D., Huestis M.A., Innis R.B. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol. Psychiatry 2012, 17:642-649.
93. Holmes A., Wellman C.L. Stress-induced prefrontal reorganization and executive dysfunction in rodents. Neurosci. Biobehav. Rev. 2009, 33:773-783.
94. Holthoff V.A., Beuthien-Baumann B., Zundorf G., Triemer A., Ludecke S., Winiecki P., Koch R., Fuchtner F., Herholz K. Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr. Scand. 2004, 110:184-194.
95. Hoover W.B., Vertes R.P. Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct. Funct. 2007, 212:149-179.
96. Howlett A.C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. 1995, 35:607-634.
97. Howlett A.C. The cannabinoid receptors. Prostaglandins Other Lipid Mediat. 2002, 68-69:619-631.
98. Howlett A.C., Bidautrussell M., Devane W.A., Melvin L.S., Johnson M.R., Herkenham M. The cannabinoid receptor - biochemical, anatomical and behavioral characterization. Trends Neurosci. 1990, 13:420-423.
99. Hungund B.L., Vinod K.Y., Kassir S.A., Basavarajappa B.S., Yalamanchili R., Cooper T.B., Mann J.J., Arango V. Upregulation of CB1 receptors and agonist-stimulated [S-35]GTP gamma S binding in the prefrontal cortex of depressed suicide victims. Mol. Psychiatry 2004, 9:184-190.
100. Hurley K.M., Herbert H., Moga M.M., Saper C.B. Efferent projections of the infralimbic cortex of the rat. J. Comp. Neurol. 1991, 308:249-276.
101. Ishikawa A., Nakamura S. Convergence and interaction of hippocampal and amygdalar projections within the prefrontal cortex in the rat. J. Neurosci. 2003, 23:9987-9995.
102. Jankord R., Herman J.P. Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stress. Ann. N. Y. Acad. Sci. 2008, 1148:64-73.
103. Ji G.C., Sun H., Fu Y., Li Z., Pais-Vieira M., Galhardo V., Neugebauer V. Cognitive impairment in pain through amygdala-driven prefrontal cortical deactivation. J. Neurosci. 2010, 30:5451-5464.
104. Jodo E., Aston-Jones G. Activation of locus coeruleus by prefrontal cortex is mediated by excitatory amino acid inputs. Brain Res. 1997, 768:327-332.
105. Jodo E., Chiang C., Aston-Jones G. Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons. Neuroscience 1998, 83:63-79.
106. Juckel G., Mendlin A., Jacobs B.L. Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression. Neuropsychopharmacology 1999, 21:391-398.
107. Kathuria S., Gaetani S., Fegley D., Valiño F., Duranti A., Tontini A., Mor M., Tarzia G., La Rana G., Calignano A., Giustino A., Tattoli M., Palmery M., Cuomo V., Piomelli D. Modulation of anxiety through blockade of anadamide hydrolysis. Nat. Med. 2003, 9:76-81.
108. Katona I., Freund T.F. Multiple functions of endocannabinoid signaling in the brain. Annu. Rev. Neurosci. 2012, 35:529-558.
109. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. Post traumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 1995, 52:1048-1060.
110. Kim M.J., Loucks R.A., Palmer A.L., Brown A.C., Solomon K.M., Marchante A.N., Whalen P.J. The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety. Behav. Brain Res. 2011, 223:403-410.
111. Kiritoshi T., Sun H., Ren W.J., Stauffer S.R., Lindsley C.W., Conn P.J., Neugebauer V. Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1. Neuropharmacology 2013, 66:170-178.
112. Klugmann M., Klippenstein V., Leweke F.M., Spanagel R., Schneider M. Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels. Int. J. Neuropsychopharmacol. 2011, 14:505-517.
113. Koenigs M., Huey E.D., Calamia M., Raymont V., Tranel D., Grafman J. Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression. J. Neurosci. 2008, 28:12341-12348.
114. Kolb B. Functions of the frontal cortex of the rat: a comparative review. Brain Res. 1984, 320:65-98.
115. Kuhnert S., Meyer C., Koch M. Involvement of cannabinoid receptors in the amygdala and prefrontal cortex of rats in fear learning, consolidation, retrieval and extinction. Behav. Brain Res. 2013, 250:274-284.
116. Lafourcade M., Elezgarai I., Mato S., Bakiri Y., Grandes P., Manzoni O.J. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS ONE 2007, 2:e709.
117. Lafourcade M., Larrieu T., Mato S., Duffaud A., Sepers M., Matias I., De Smedt-Peyrusse V., Labrousse V.F., Bretillon L., Matute C., Rodriguez-Puertas R., Laye S., Manzoni O.J. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci. 2011, 14:345-350.
118. Laviolette S.R., Grace A.A. Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs. J. Neurosci. 2006, 26:6458-6468.
119. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 2000, 23:155-184.
120. Lee T.T., Gorzalka B.B. Timing is everything: evidence for a role of corticolimbic endocannabinoids in modulating hypothalamic-pituitary-adrenal axis activity across developmental periods. Neuroscience 2012, 204:17-30.
121. Lee T.T., Hill M.N. Age of stress exposure modulates the immediate and sustained effects of repeated stress on corticolimbic cannabinoid CB1 receptor binding in male rats. Neuroscience 2013, 249:106-114.
122. Lee T.T., Hill M.N., Hillard C.J., Gorzalka B.B. Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period. Synapse 2013, 67:4-10.
123. Lemos J.I., Resstel L.B., Guimaraes F.S. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats. Behav. Brain Res. 2010, 207:105-111.
124. Lin H.C., Mao S.C., Su C.L., Gean P.W. The role of prefrontal cortex CB1 receptors in the modulation of fear memory. Cereb. Cortex 2009, 19:165-175.
125. Lisboa S.F., Reis D.G., da Silva A.L., Correa F.M., Guimaraes F.S., Resstel L.B. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning. Int. J. Neuropsychopharmacol. 2010, 13:1163-1173.
126. Liston C., Miller M.M., Goldwater D.S., Radley J.J., Rocher A.B., Hof P.R., Morrison J.H., McEwen B.S. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J. Neurosci. 2006, 26:7870-7874.
127. Loughlin S.E., Fallon J.H. Substantia nigra and ventral tegmental area projections to cortex: topography and collateralization. Neuroscience 1984, 11:425-435.
128. Mailleux P., Parmentier M., Vanderhaeghen J.J. Distribution of cannabinoid receptor messenger-RNA in the human brain - an in situ hybridization histochemistry with oligonucleotides. Neurosci. Lett. 1992, 143:200-204.
129. Mailleux P., Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain - a comparative receptor-binding autoradiography and in situ hybridization histochemistry. Neuroscience 1992, 48:655-668.
130. Marco E.M., García-Gutiérrez M.S., Bermúdez-Silva F.J., Moreira F.A., Guimarães F., Manzanares J., Viveros M.P. Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. Front. Behav. Neurosci. 2011, 5(63):1-23.
131. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 1999, 11:4213-4225.
132. Massi P., Valenti M., Bolognini D., Parolaro D. Expression and function of the endocannabinoid system in glial cells. Curr. Pharm. Des. 2008, 14:2289-2298.
133. Mato S., Pazos A. Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain. Neuropharmacology 2004, 46:716-726.
134. Mato S., Vidal R., Castro E., Diaz A., Pazos A., Valdizan E.M. Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine(1A) receptor-dependent mechanisms. Mol. Pharmacol. 2010, 77:424-434.
135. Matsuda L.A., Bonner T.I., Lolait S.J. Localization of cannabinoid receptor messenger-RNA in rat brain. J. Comp. Neurol. 1993, 327:535-550.
136. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
137. Matsumoto M., Togashi H., Mori K., Ueno K., Miyamoto A., Yoshioka M. Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex. Eur. J. Pharmacol. 1999, 383:39-48.
138. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., Jerabek P.A. Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biol. Psychiatry 2000, 48:830-843.
139. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., Schwalb J.M., Kennedy S.H. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
140. McEwen B.S. Protective and damaging effects of stress mediators: central role of the brain. Dialogues Clin Neurosci 2006, 8:367-381.
141. McEwen B.S., Morrison J.H. The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course. Neuron 2013, 79:16-29.
142. McLaughlin K.J., Baran S.E., Conrad C.D. Chronic stress- and sex-specific neuromorphological and functional changes in limbic structures. Mol. Neurobiol. 2009, 40:166-182.
143. McLaughlin R.J., Bambico F.R., Gobbi G. Role of the endocannabinoid system in etiopathology of major depression. Frontiers in Neuroscience: Neurobiology of Depression 2011, 205-224. CRC Press (Taylor & Francis Group), London. F. López-Muñoz, C. Álamo (Eds.).
144. McLaughlin R.J., Hill M.N., Bambico F.R., Stuhr K.L., Gobbi G., Hillard C.J., Gorzalka B.B. Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway. Eur. Neuropsychopharmacol. 2012, 22:664-671.
145. McLaughlin R.J., Hill M.N., Dang S.S., Wainwright S.R., Galea L.A.M., Hillard C.J., Gorzalka B.B. Upregulation of CB1 receptor binding in the ventromedial prefrontal cortex promotes proactive stress-coping strategies following chronic stress exposure. Behav. Brain Res. 2013, 237:333-337.
146. Michelsen K.A., van den Hove D.L., Schmitz C., Segers O., Prickaerts J., Steinbusch H.W. Prenatal stress and subsequent exposure to chronic mild stress influence dendritic spine density and morphology in the rat medial prefrontal cortex. BMC Neurosci. 2007, 8:107.
147. Milad M.R., Quirk G.J. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 2002, 420:70-74.
148. Mizoguchi K., Ishige A., Aburada M., Tabira T. Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus. Neuroscience 2003, 119:887-897.
149. Mizoguchi K., Shoji H., Ikeda R., Tanaka Y., Tabira T. Persistent depressive state after chronic stress in rats is accompanied by HPA axis dysregulation and reduced prefrontal dopaminergic neurotransmission. Pharmacol. Biochem. Behav. 2008, 91:170-175.
150. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Chui D.H., Tabira T. Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction. J. Neurosci. 2000, 20:1568-1574.
151. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Tabira T. Chronic stress impairs rotarod performance in rats: implications for depressive state. Pharmacol. Biochem. Behav. 2002, 71:79-84.
152. Monory K., Blaudzun H., Massa F., Kaiser N., Lemberger T., Schtuz G., Wotjak C.T., Lutz B., Marsicano G. Genetic dissection of behavioural and autonomic effects of delta 9-tetrahydrocannabinol in mice. PLoS Biol. 2007, 5:2354-2368.
153. Monory K., Massa F., Egertova M., Eder M., Blaudzun H., Westenbroek R., Kelsch W., Jacob W., Marsch R., Ekker M., Long J., Rubenstein J.L., Goebbels S., Nave K.A., During M., Klugmann M., Wolfel B., Dodt H.U., Zieglgansberger W., Wotjak C.T., Mackie K., Elphick M.R., Marsicano G., Lutz B. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 2006, 51:455-466.
154. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
155. Moreira F.A., Aguiar D.C., Terzian A.L., Guimarães F.S., Wotjak C.T. Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?. Neuroscience 2012, 204:186-192.
156. Muguruza C., Lehtonen M., Aaltonen N., Morentin B., Meana J.J., Callado L.F. Quantification of endocannabinoids in postmortem brain of schizophrenic subjects. Schizophr. Res. 2013, 148:145-150.
157. Munro S., Thomas K.L., Abushaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
158. Muntoni A.L., Pillolla G., Melis M., Perra S., Gessa G.L., Pistis M. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. Eur. J. Neurosci. 2006, 23:2385-2394.
159. Myers-Schulz B., Koenigs M. Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders. Mol. Psychiatry 2012, 17:132-141.
160. Neumeister A., Normandin M.D., Pietrzak R.H., Piomelli D., Zheng M.Q., Gujarro-Anton A., Potenza M.N., Bailey C.R., Lin S.F., Najafzadeh S., Ropchan J., Henry S., Corsi-Travali S., Carson R.E., Huang Y. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol. Psychiatry 2013, 18:1034-1040.
161. Neumeister A., Nugent A.C., Waldeck T., Geraci M., Schwarz M., Bonne O., Bain E.E., Luckenbaugh D.A., Herscovitch P., Charney D.S., Drevets W.C. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch. Gen. Psychiatry 2004, 61:765-773.
162. Newell K.A., Deng C., Huang X.F. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Exp. Brain Res. 2006, 172:556-560.
163. Nobler M.S., Oquendo M.A., Kegeles L.S., Malone K.M., Campbell C., Sackeim H.A., Mann J.J. Decreased regional brain metabolism after ECT. Am. J. Psychiatry 2001, 158:305-308.
164. Onaivi E.S. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 2006, 54:231-246.
165. Onaivi E.S., Ishiguro H., Gong J.P., Patel S., Meozzi P.A., Myers L., Perchuk A., Mora Z., Tagliaferro P.A., Gardner E., Brusco A., Akinshola B.E., Liu Q.R., Chirwa S.S., Hope B., Lujilde J., Inada T., Iwasaki S., Macharia D., Teasenfitz L., Arinami T., Uhl G.R. Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Ann. N. Y. Acad. Sci. 2008, 1139:434-449.
166. Ong W.Y., Mackie K. A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience 1999, 92:1177-1191.
167. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:13290-13295.
168. Ongur D., Ferry A.T., Price J.L. Architectonic subdivision of the human orbital and medial prefrontal cortex. J. Comp. Neurol. 2003, 460:425-449.
169. Ongur D., Price J.L. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb. Cortex 2000, 10:206-219.
170. Oropeza V.C., Page M.E., Van Bockstaele E.J. Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex. Brain Res. 2005, 1046:45-54.
171. Ortega-Alvaro A., Aracil-Fernandez A., García-Gutiérrez M.S., Navarrete F., Manzanares J. Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology 2011, 36:1489-1504.
172. Owen C., Rees A.M., Parker G. The role of fatty acids in the development and treatment of mood disorders. Curr. Opin. Psychiatry 2008, 21:19-24.
173. Page M.E., Oropeza V.C., Van Bockstaele E.J. Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex. Neurosci. Lett. 2008, 431:1-5.
174. Pan B., Wang W., Zhong P., Blankman J.L., Cravatt B.F., Liu Q.S. Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice. J. Neurosci. 2011, 31:13420-13430.
175. Parsons R.G., Ressler K.J. Implications of memory modulation for post-traumatic stress and fear disorders. Nat. Neurosci. 2013, 16:146-153.
176. Passie T., Emrich H.M., Karst M., Brandt S.D., Halpern J.H. Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence. Drug Test Anal. 2012, 4:649-659.
177. Patel S., Hillard C.J. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J. Pharmacol. Exp. Ther. 2006, 318:304-311.
178. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004, 145:5431-5438.
179. Patel S., Roelke C.T., Rademacher D.J., Hillard C.J. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur. J. Neurosci. 2005, 21:1057-1069.
180. Pattwell S.S., Lee F.S., Casey B.J. Fear learning and memory across adolescent development: hormones and behavior special issue: puberty and adolescence. Horm. Behav. 2013, 64:380-389.
181. Phelps E.A., Delgado M.R., Nearing K.I., LeDoux J.E. Extinction learning in humans: role of the amygdala and vmPFC. Neuron 2004, 43:897-905.
182. Pistis M., Ferraro L., Pira L., Flore G., Tanganelli S., Gessa G.L., Devoto P. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res. 2002, 948:155-158.
183. Pizzagalli D.A., Oakes T.R., Fox A.S., Chung M.K., Larson C.L., Abercrombie H.C., Schaefer S.M., Benca R.M., Davidson R.J. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol. Psychiatry 2004, 9(325):393-405.
184. Preuss T.M. Do rats have prefrontal cortex? The rose-woolsey-akert program reconsidered. J. Cogn. Neurosci. 1995, 7:1-24.
185. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010, 35:192-216.
186. Rabinak C.A., Phan K.L. Cannabinoid modulation of fear extinction brain circuits: a novel target to advance anxiety treatment. Curr. Pharm. Des. 2013, PMID: 23829364, June 14 (epub ahead of print).
187. Rademacher D.J., Meier S.E., Shi L.Y., Ho W.S.V., Jarrahian A., Hillard C.J. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 2008, 54:108-116.
188. Radley J.J., Anderson R.M., Hamilton B.A., Alcock J.A., Romig-Martin S.A. Chronic stress-induced alterations of dendritic spine subtypes predict functional decrements in an hypothalamo-pituitary-adrenal-inhibitory prefrontal circuit. J. Neurosci. 2013, 33:14379-14391.
189. Radley J.J., Arias C.M., Sawchenko P.E. Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress. J. Neurosci. 2006, 26:12967-12976.
190. Radley J.J., Gosselink K.L., Sawchenko P.E. A discrete GABAergic relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response. J. Neurosci. 2009, 29:7330-7340.
191. Radley J.J., Rocher A.B., Janssen W.G., Hof P.R., McEwen B.S., Morrison J.H. Reversibility of apical dendritic retraction in the rat medial prefrontal cortex following repeated stress. Exp. Neurol. 2005, 196:199-203.
192. Radley J.J., Rocher A.B., Miller M., Janssen W.G., Liston C., Hof P.R., McEwen B.S., Morrison J.H. Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex. Cereb. Cortex 2006, 16:313-320.
193. Radley J.J., Rocher A.B., Rodriguez A., Ehlenberger D.B., Dammann M., McEwen B.S., Morrison J.H., Wearne S.L., Hof P.R. Repeated stress alters dendritic spine morphology in the rat medial prefrontal cortex. J. Comp. Neurol. 2008, 507:1141-1150.
194. Radley J.J., Sawchenko P.E. A common substrate for prefrontal and hippocampal inhibition of the neuroendocrine stress response. J. Neurosci. 2011, 31:9683-9695.
195. Ramos A., Mormede P. Stress and emotionality: a multidimensional and genetic approach. Neurosci. Biobehav. Rev. 1998, 22:33-57.
196. Reich C.G., Taylor M.E., McCarthy M.M. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behav. Brain Res. 2009, 203:264-269.
197. Rey A.A., Purrio M., Viveros M.P., Lutz B. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology 2012, 37:2624-2634.
198. Rodriguez-Gaztelumendi A., Rojo M.L., Pazos A., Diaz A. Altered CB1 receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine. J. Neurochem. 2009, 108:1423-1433.
199. Room P., Russchen F.T., Groenewegen H.J., Lohman A.H. Efferent connections of the prelimbic (area 32) and the infralimbic (area 25) cortices: an anterograde tracing study in the cat. J. Comp. Neurol. 1985, 242:40-55.
200. Rose J.E., Woolsey C.N. The orbitofrontal cortex and its connections with the mediodorsal nucleus in rabbit, sheep and cat. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 1948, 27:210-232.
201. Rosenkranz J.A., Grace A.A. Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J. Neurosci. 2002, 22:324-337.
202. Rubino T., Guidali C., Vigano D., Realini N., Valenti M., Massi P., Parolaro D. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. Neuropharmacology 2008, 54:151-160.
203. Rubino T., Realini N., Castiglioni C., Guidali C., Vigano D., Marras E., Petrosino S., Perletti G., Maccarrone M., Di Marzo V., Parolaro D. Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb. Cortex 2008, 18:1292-1301.
204. Schlosburg J.E., Blankman J.L., Long J.Z., Nomura D.K., Pan B., Kinsey S.G., Nguyen P.T., Ramesh D., Booker L., Burston J.J., Thomas E.A., Selley D.E., Sim-Selley L.J., Liu Q.S., Lichtman A.H., Cravatt B.F. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat. Neurosci. 2010, 13:1113-1119.
205. Sciolino N.R., Bortolato M., Eisenstein S.A., Fu J., Oveisi F., Hohmann A.G., Piomelli D. Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats. Neuroscience 2010, 168:371-386.
206. Sciolino N.R., Zhou W., Hohmann A.G. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. Pharmacol. Res. 2011, 64:226-234.
207. Seamans J.K., Lapish C.C., Durstewitz D. Comparing the prefrontal cortex of rats and primates: insights from electrophysiology. Neurotox. Res. 2008, 14:249-262.
208. Shansky R.M., Lipps J. Stress-induced cognitive dysfunction: hormone-neurotransmitter interactions in the prefrontal cortex. Front. Hum. Neurosci. 2013, 7:123.
209. Sim-Selley L.J., Vogt L.J., Vogt B.A., Childers S.R. Cellular localization of cannabinoid receptors and activated G-proteins in rat anterior cingulate cortex. Life Sci. 2002, 71:2217-2226.
210. Starowicz K., Nigam S., Di Marzo V. Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther. 2007, 114:13-33.
211. Steiner M.A., Marsicano G., Nestler E.J., Holsboer F., Lutz B., Wotjak C.T. Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology 2008, 33:54-67.
212. Steiner M.A., Marsicano G., Wotjak C.T., Lutz B. Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. Psychoneuroendocrinology 2008, 33:1165-1170.
213. Steiner M.A., Wotjak C.T. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. Prog. Brain Res. 2008, 170:397-432.
214. Stewart S.H., Pihl R.O., Conrod P.J., Dongier M. Functional associations among trauma, PTSD, and substance-related disorders. Addict. Behav. 1998, 23:797-812.
215. Sugiura T., Kobayashi Y., Oka S., Waku K. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostag. Leukotr. Ess. 2002, 66:173-192.
216. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 2-Arachidonoylgylcerol - a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 1995, 215:89-97.
217. Sumislawski J.J., Ramikie T.S., Patel S. Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. Neuropsychopharmacology 2011, 36:2750-2761.
218. Takagishi M., Chiba T. Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: an anterograde tracer PHA-L study. Brain Res. 1991, 566:26-39.
219. Tanda G., Carboni E., Frau R., Di Chiara G. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?. Psychopharmacology 1994, 115:285-288.
220. Trettel J., Fortin D.A., Levine E.S. Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J. Physiol. (Lond.) 2004, 556:95-107.
221. Trezza V., Campolongo P. The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD). Front Behav Neurosci. 2013, 7:100.
222. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
223. Uylings H.B., Groenewegen H.J., Kolb B. Do rats have a prefrontal cortex?. Behav. Brain Res. 2003, 146:3-17.
224. Uylings H.B., van Eden C.G. Qualitative and quantitative comparison of the prefrontal cortex in rat and in primates, including humans. Prog. Brain Res. 1990, 85:31-62.
225. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., Marnett L.J., Di Marzo V., Pittman Q.J., Patel K.D., Sharkey K.A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310:329-332.
226. Vertes R.P. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 2004, 51:32-58.
227. Vertes R.P. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 2006, 142:1-20.
228. Vinod K.Y., Arango V., Xie S., Kassir S.A., Mann J.J., Cooper T.B., Hungund B.L. Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide. Biol. Psychiatry 2005, 57:480-486.
229. Wade M.R., Degroot A., Nomikos G.G. Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents. Eur. J. Pharmacol. 2006, 551:162-167.
230. Wang M.N., Hill M.N., Zhang L.H., Gorzalka B.B., Hillard C.J., Alger B.E. Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. J. Psychopharmacol. 2012, 26:56-70.
231. Wedzony K., Chocyk A. Cannabinoid CB1 receptors in rat medial prefrontal cortex are colocalized with calbindin- but not parvalbumin- and calretinin-positive GABAergic neurons. Pharmacol. Rep. 2009, 61:1000-1007.
232. Wellman C.L. Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol 2001, 49:245-253.
233. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
234. Yoshino H., Miyamae T., Hansen G., Zambrowicz B., Flynn M., Pedicord D., Blat Y., Westphal R.S., Zaczek R., Lewis D.A., Gonzalez-Burgos G. Postsynaptic diacylglycerol lipase alpha mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J. Physiol. (Lond.) 2011, 589:4857-4884.
235. Zavitsanou K., Garrick T., Huang X.F. Selective antagonist [H-3]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:355-360.
236. Zoppi S., Nievas B.G.P., Madrigal J.L.M., Manzanares J., Leza J.C., Garcia-Bueno B. Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Neuropsychopharmacology 2011, 36:805-818.